News

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI

14-10-2013

Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

US FDA fast-track for Sanofi Pasteur's KB001A; orphan status for Teva/Xenon's XEN402; second BD Simplist product approved

23-04-2013

Among a flurry of news items from the US Food and Drug Administration, was notification that Sanofi Pasteur,…

Antibiotics and Infectious diseasesBD SimplistBecton DickinsonKaloBios PharmaceuticalsKB001ANeurologicalNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurTeva Pharmaceutical IndustriesXEN402Xenon Pharmaceuticals

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

01-05-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

Cubist Pharma leaps 14% on settling Cubicin patent litigation with Teva

06-04-2011

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) saw its shares soar 14% to $28.90 in extending trading…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsNorth AmericaPatentsPharmaceuticalTeva Pharmaceutical Industries

COMPANY SPOTLIGHT

Menarini

Back to top